EBIT: Income before interest and taxes.
Immunome, Inc. (IMNM) had EBIT of $-46.48M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$4.01M |
|
$-43.40M |
|
-- |
|
$4.01M |
|
$50.49M |
|
$-46.48M |
|
$3.08M |
|
$-43.40M |
|
$-43.40M |
|
$-43.40M |
|
$-43.40M |
|
$-43.40M |
|
$-43.40M |
|
|
EBIT |
$-46.48M |
$-46.96M |
|
87.01M |
|
87.01M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$277.43M |
|
$11.03M |
|
$18.86M |
|
$296.29M |
|
$22.88M |
|
-- |
|
$4.14M |
|
$27.02M |
|
$269.27M |
|
$269.27M |
|
$269.27M |
|
87.01M |
|
| Cash Flow Statement Financials | |
$-102.46M |
|
$-59.08M |
|
$162.17M |
|
$143.45M |
|
$144.09M |
|
$0.64M |
|
$11.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
12.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1157.61% |
|
-1157.61% |
|
-- |
|
-1080.87% |
|
-1080.87% |
|
$-107.03M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-16.12% |
|
-16.12% |
|
-14.65% |
|
-16.12% |
|
$3.09 |
|
$-1.23 |
|
$-1.18 |
|